Therefore, the elevated levels of leptin observed in the PSO–MS group are consistent with the existing literature and may indicate a more prominent inflammatory response and a pathological connection between the systemic inflammation associated with metabolic syndrome and the localized inflammation characteristic of psoriasis [55,57,58]. The gene discussed is LEP; the disease is metabolic syndrome.